Name | (4R)-5-(4-chlorophenyl)-N-(4-chlorophenyl)sulfonyl-N'-methyl-4-phenyl-3,4-dihydropyrazole-2-carboximidamide |
---|---|
Synonyms |
1H-Pyrazole-1-carboximidamide, 3-(4-chlorophenyl)-N'-[(4-chlorophenyl)sulfonyl]-4,5-dihydro-N-methyl-4-phenyl-
3-(4-chlorophenyl)-N-methyl-N'-((4-chlorophenyl)sulfonyl)-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboxamidine 3-(4-Chlorophenyl)-N-[(4-chlorophenyl)sulfonyl]-N'-methyl-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboximidamide 1H-pyrazole-1-carboximidamide, 3-(4-chlorophenyl)-N-[(4-chlorophenyl)sulfonyl]-4,5-dihydro-N'-methyl-4-phenyl- |
Description | (R)-SLV 319 is a potent and selective cannabinoid receptor 1 (CB1) antagonist with a Ki value of 894 nM. (R)-SLV 319 is a dextrorotatory counterpart of SLV 319[1] |
---|---|
Related Catalog | |
Target |
CB1:894 nM (Ki) |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 623.2±65.0 °C at 760 mmHg |
Molecular Formula | C23H20Cl2N4O2S |
Molecular Weight | 487.40 |
Flash Point | 330.7±34.3 °C |
Exact Mass | 486.068390 |
PSA | 82.51000 |
LogP | 4.67 |
Vapour Pressure | 0.0±1.8 mmHg at 25°C |
Index of Refraction | 1.663 |